Observational study / 2022
IgE sensitization to α-Gal was linked to noncalcified plaque, obstructive CAD, and STEMI.
In a cross-sectional study using the BioHEART cohort, researchers measured α-Gal specific-IgE antibodies in 1,056 patients referred for CT coronary angiography and 100 selected patients presenting with STEMI. α-Gal sensitization was associated with the presence of noncalcified plaque (OR 1.62 [95% CI, 1.04-2.53], P=0.03) and obstructive CAD (OR 2.05 [95% CI, 1.29-3.25], P=0.002), independent of age, sex, and traditional risk factors. The sensitization rate was 12.8-fold higher in STEMI patients versus matched healthy controls (17% vs 1.3%, P=0.01) and 2.2-fold higher versus matched stable CAD patients (20% vs 9%, P=0.03).
Shows an association, not proof of cause and effect.
- Study type
- Cross-sectional analysis
- Who was studied
- 1,056 patients referred for CT coronary angiography for suspected CAD and 100 selected patients presenting with STEMI
- What was measured
- Presence of noncalcified plaque, obstructive CAD, and STEMI
THE PAPER
Immunoglobulin E Sensitization to Mammalian Oligosaccharide Galactose-α-1,3 (α-Gal) Is Associated With Noncalcified Plaque, Obstructive Coronary Artery Disease, and ST-Segment-Elevated Myocardial Infarction.
Vernon ST, Kott KA, Hansen T, Finemore M, Baumgart KW, Bhindi R, Yang J, Hansen PS, Nicholls SJ, Celermajer DS, Ward MR, van Nunen SA, Grieve SM, Figtree GA. Arterioscler Thromb Vasc Biol, 2022.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.